- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (7)
4 result(s) found for: Giardia.
Displaying page 1 of 1.
| EudraCT Number: 2016-001938-96 | Sponsor Protocol Number: PGLIT2016 | Start Date*: 2016-12-22 |
| Sponsor Name:Helsinki University Central Hospital | ||
| Full Title: Treatment of Giardia lamblia infections in children: randomized open-labeled trial comparing rectal metronidazole with oral tinidazole | ||
| Medical condition: Symptomatic Giardia lamblia infections in children | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001199-39 | Sponsor Protocol Number: MulticenterEbastineIBS | Start Date*: 2013-11-21 |
| Sponsor Name:KULeuven | ||
| Full Title: Histamine 1 receptor antagonist ebastine as novel treatment in IBS | ||
| Medical condition: Patients who suffer from irritable bowel syndrome which are diarrhea predominant and mixed (alteration of constipation and diarrhea) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-003690-65 | Sponsor Protocol Number: 78304 | Start Date*: 2021-11-10 |
| Sponsor Name:St Antonius Hospital | ||
| Full Title: Peppermint Oil for the treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT study | ||
| Medical condition: Irritable Bowel syndrome Functional Abdominal Pain Not otherwise specified | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-003293-32 | Sponsor Protocol Number: Duski2015 | Start Date*: 2017-11-06 | ||||||||||||||||
| Sponsor Name:Academic Medical Center | ||||||||||||||||||
| Full Title: Multicentre, Randomised, Placebo-Controlled Trial of Mebeverine in Children with Irritable Bowel Syndrome (IBS) or Functional Abdominal Pain - not otherwise specified (FAP-NOS) | ||||||||||||||||||
| Medical condition: Functional Gastrointestinal Disorders (Irritable Bowel Syndrome or Functional Abdominal Pain - not otherwise specified) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.